» Articles » PMID: 36910052

Recipient, Donor, and Surgical Factors Leading to Primary Graft Dysfunction After Lung Transplant

Overview
Journal J Thorac Dis
Specialty Pulmonary Medicine
Date 2023 Mar 13
PMID 36910052
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Primary graft dysfunction is a major cause of early mortality following lung transplantation. The International Society for Heart and Lung Transplantation subdivides it into 4 grades of increasing severity.

Methods: A retrospective review of the institutional lung transplant database from March 2018 to September 2021 was performed. Patients were stratified into three groups: primary graft dysfunction grade 0 patients, grade 1 or 2 patients, and grade 3 patients. Recipient, donor, and surgical variables were analyzed by logistic regression analysis to identify risk factors for primary graft dysfunction grade 1 or 2 and grade 3.

Results: Primary graft dysfunction grade 1 to 3 occurred in 45.0% of the cohort (n=68) of whom 33.3% (n=23) had primary graft dysfunction grade 3. Longer operative time was more common in primary graft dysfunction grade 1 to 3 patients (P<0.001). The 1-year survival of the patients with primary graft dysfunction grade 3 was lower than the others (grade 0-2 3, 93.7% 65.2%, P=0.0006). Univariate analysis showed that acute respiratory distress syndrome, operative time, and intraoperative veno-arterial extracorporeal membrane oxygenation use were risk factors for primary graft dysfunction grades 1 or 2 and grade 3. Multivariate analysis identified that intraoperative veno-arterial extracorporeal membrane oxygenation use was an independent risk factor of primary graft dysfunction grade 1 or 2. Patients with an operative time of more than 8.18 hours had significantly higher incidence of primary graft dysfunction grade 3, acute kidney injury, and digital ischemia.

Conclusions: The calculated predictors of primary graft dysfunction grade 1 or 2 were similar to those of primary graft dysfunction grade 3.

Citing Articles

Contrasting predictors of severe primary graft dysfunction following transplant for chronic and acute respiratory failure.

Kurihara C, Kaiho T, Thomae B, Cerier E, Lung K, Avella Patino D J Thorac Dis. 2024; 16(8):5050-5062.

PMID: 39268121 PMC: 11388248. DOI: 10.21037/jtd-24-100.


Analysis of Primary Graft Dysfunction (PGD) Risk Factors in Lung Transplantation (LuTx) Patients.

Kubisa M, Wojtys M, Lisowski P, Kordykiewicz D, Piotrowska M, Wojcik J Clin Pract. 2024; 14(4):1571-1583.

PMID: 39194931 PMC: 11352894. DOI: 10.3390/clinpract14040127.


A novel nomogram for predicting prolonged mechanical ventilation in lung transplantation patients using extracorporeal membrane oxygenation.

Xuan C, Gu J, Xu Z, Chen J, Xu H Sci Rep. 2024; 14(1):11692.

PMID: 38778128 PMC: 11111670. DOI: 10.1038/s41598-024-62601-2.


Primary graft dysfunction in lung transplantation: still a thorn in the side of lung transplant.

Wong K, Hsin K J Thorac Dis. 2024; 16(1):1-5.

PMID: 38410540 PMC: 10894369. DOI: 10.21037/jtd-23-1618.


Temporal correlation between postreperfusion complement deposition and severe primary graft dysfunction in lung allografts.

Cerier E, Kurihara C, Kaiho T, Toyoda T, Manerikar A, Kandula V Am J Transplant. 2023; 24(4):577-590.

PMID: 37977230 PMC: 10982049. DOI: 10.1016/j.ajt.2023.11.006.


References
1.
Cantu E, Shah R, Lin W, Daye Z, Diamond J, Suzuki Y . Oxidant stress regulatory genetic variation in recipients and donors contributes to risk of primary graft dysfunction after lung transplantation. J Thorac Cardiovasc Surg. 2014; 149(2):596-602. PMC: 4346512. DOI: 10.1016/j.jtcvs.2014.09.077. View

2.
Kurihara C, Walter J, Karim A, Thakkar S, Saine M, Odell D . Feasibility of Venovenous Extracorporeal Membrane Oxygenation Without Systemic Anticoagulation. Ann Thorac Surg. 2020; 110(4):1209-1215. PMC: 7486253. DOI: 10.1016/j.athoracsur.2020.02.011. View

3.
Magouliotis D, Tasiopoulou V, Svokos A, Svokos K, Zacharoulis D . Extracorporeal membrane oxygenation versus cardiopulmonary bypass during lung transplantation: a meta-analysis. Gen Thorac Cardiovasc Surg. 2017; 66(1):38-47. DOI: 10.1007/s11748-017-0836-3. View

4.
Burton C, Iversen M, Milman N, Zemtsovski M, Carlsen J, Steinbruchel D . Outcome of lung transplanted patients with primary graft dysfunction. Eur J Cardiothorac Surg. 2006; 31(1):75-82. DOI: 10.1016/j.ejcts.2006.10.024. View

5.
Tomasko J, Prasad S, Dell D, DeCamp M, Bharat A . Therapeutic anticoagulation-free extracorporeal membrane oxygenation as a bridge to lung transplantation. J Heart Lung Transplant. 2016; 35(7):947-8. DOI: 10.1016/j.healun.2016.04.005. View